Separate promising research from proven care.
posted on
By the Regenerative Evidence Guide Team One Instruction in Your Recovery Plan. Is It Evidence, or Just Custom? This guide has one job: helping you check whether a specific instruction in your …
Continue Reading about Recovery Claims After a Procedure: Separating Protocol From Proof →
posted on
By the Regenerative Evidence Guide Team The Reader's Decision Point A clinic points to a specific completed trial and tells you what it found. That trial has posted results on its public registry …
posted on
By the Regenerative Evidence Guide Team What It Means When a Registry Entry Changes A study registry entry is the public record of a research study on a site like ClinicalTrials.gov. The people …
Continue Reading about A Registry Entry Changed: How to Record the Version and Date →
posted on
By the Regenerative Evidence Guide Team A study with only a few participants mostly lacks precision. Its results give a rough estimate of what a treatment might do, with a wide range of possible true …
Continue Reading about A Regenerative Study Has a Small Sample: What Precision Is Missing →
posted on
By the Regenerative Evidence Guide Team What "Safety Outcomes" Means on a Trial Listing When a clinical trial lists safety outcomes, it is reporting adverse events. These are unwanted medical events …
Continue Reading about A Trial Lists Safety Outcomes: What Events Were Counted and When →
posted on
By the Regenerative Evidence Guide Team If you saw an exosome headline and want to know what it means for a real person, start with two questions. First: what exact product was studied? Second: was it …
Continue Reading about Exosome Research Headlines: Product Identity and Human Evidence Questions →